Contraindications & Patient Selection
Evidence-based screening criteria for safe medicinal leech therapy
Clinical Evidence — Not FDA-Evaluated
This page consolidates patient selection criteria and contraindication data from published clinical guidelines, systematic reviews, and institutional protocols. Practitioners must adapt screening to their specific clinical setting and comply with applicable scope-of-practice laws.
Absolute Contraindications
Absolute contraindications: leech therapy is not performed. The list follows the A-level hirudotherapy books — Baskova & Isakhanyan, ch. 17, and Michalsen, Roth & Dobos, ch. 8 — and matches the patient guide.
Concurrent Anticoagulants
Warfarin (Marcumar), heparin and heparinoids are an absolute contraindication[B3]; Baskova & Isakhanyan list concurrent anticoagulants, especially long-term daily use[B1]. Direct oral anticoagulants belong to the same class. Whether an anticoagulant may be paused is decided only by the prescribing physician. Sukhov (book 2, level B) treats anticoagulants as manageable in agreement with the treating physician; this site follows the A-level books.
Anemia or Bone-Marrow Suppression
Any treatment that removes blood is generally contraindicated in anemia or bone-marrow suppression[B3][B1]. Blood counts should always be obtained before leech therapy is started[B3]. In hospital microsurgery about half of patients receiving leech therapy need a transfusion (Whitaker 2012).
Hypotension, Shock, Collapse, Syncope
Listed as contraindications by Baskova & Isakhanyan[B1]. Michalsen notes the blood-pressure-lowering effect of leeching, especially with antihypertensive medication, and vasovagal syncope in patients with such a history[B3]. Kamenev (level B) disputes hypotension as a contraindication and uses fewer leeches instead; this site follows the A-level books.
Intolerance & Severe Allergic Diathesis
Individual intolerance[B1], or a history of severe allergic diathesis or severe systemic reactions[B3]. With only mild or uncertain intolerance reactions, leech therapy may be performed with concomitant antihistamines[B3]. Local itching is common and is not an allergic reaction[B3].
Peptic Ulcer or Erosive Gastritis
Upper gastrointestinal bleeding occurred the day after leeching in a patient with erosive gastritis; leech therapy should not be performed with known peptic ulcer or erosive gastritis[B3].
Acute Infectious Disease, High Fever, Sepsis
Not recommended during the acute stage of an infectious disease, which may lead to weakness and impaired wound healing[B3]; Baskova & Isakhanyan advise against treatment with a high body temperature[B1]. Systemic infection with bacteremia: defer treatment until it has resolved.
Severe Unstable Illness, Marked Immunosuppression, HIV
Never in severe, unstable organic disease or marked immunosuppression such as chemotherapy; contraindicated in HIV infection[B3]. Active leukemia or lymphoma and decompensated liver disease with coagulopathy belong here.
Alcohol
Concurrent alcohol intake[B1].
Arterial Insufficiency of Replanted or Transplanted Tissue
Developed arterial insufficiency of a replanted or transplanted area, because the arterial block protects the damaged tissue from filling with blood[B1].
Relative Contraindications
Relative contraindications require individualized risk-benefit analysis. Treatment may proceed with appropriate precautions, modified protocols, or specialist consultation.
Aspirin & Clopidogrel
ModerateNot contraindications by themselves[B3]. Ask about bleeding tendencies; with low-dose aspirin combined with another antiplatelet such as clopidogrel, or with high-dose fish oil, start with three to four leeches[B3]. If aspirin and clopidogrel are combined, clopidogrel is stopped five days before leech therapy only if medically feasible[B3].
Mitigation: Fewer leeches at the first session; aspirin and other prescribed medicines are never stopped for leech therapy without the treating physician (cardiology after a recent stent); high-dose fish oil and ginkgo are paused before treatment[B3]. Other NSAIDs are not addressed in the books — decide individually.
Diabetes & Impaired Wound Healing
ModerateDiseases with impaired wound healing such as diabetes mellitus are relative contraindications; evaluate the history[B3]. Do not apply leeches directly to areas of impaired healing such as leg ulcers, which can become foci of new ulcers[B3].
Mitigation: Confirm arterial perfusion of the target tissue; antibiotics as the physician decides (up to three days in patients with multiple comorbidities)[B3]; enhanced wound monitoring.
Severe Chronic Stable Disease & Corticosteroids
Moderate–HighSevere chronic but stable organ diseases — cirrhosis (coagulation!), connective-tissue and immune diseases, dialysis, diseases of the blood-forming organs — are relative contraindications[B3]. Corticosteroids in low to medium doses are acceptable without wound-healing disorders or cortisone skin changes[B3].
Keloid Tendency
Low–ModerateBites can cause keloids in patients who tend to form them — ask about the history of scarring[B3]. Ordinary marks fade: within one to three weeks according to Michalsen[B3], within one to four months according to Sukhov[B2].
Mitigation: Informed consent with disclosure of possible marks; avoid cosmetically sensitive areas[B1].
Surgical Patients Who Cannot Take Antibiotics
Moderate–HighConcomitant antibiotics are recommended for all surgical patients, starting at least six hours before leech therapy[B3].
Mitigation: Choose the agent according to local resistance: ciprofloxacin-resistant Aeromonas has been reported after leech therapy, so ciprofloxacin alone may not protect (Giltner 2013; Brauer 2024).
Drug Interactions
Medicinal leech salivary gland secretion contains multiple pharmacologically active compounds that interact with anticoagulant, antiplatelet, and anti-inflammatory medications. The table below summarizes clinically significant interactions.
| Medication Class | Severity | Mechanism | Management |
|---|---|---|---|
| Warfarin | High | Additive anticoagulation: warfarin (vitamin K antagonist) + hirudin (direct thrombin inhibitor) + factor Xa inhibitors in SGS | Concurrent use is a contraindication[B1][B3]. Pausing or bridging is decided only by the prescribing physician. |
| Direct Oral Anticoagulants (DOACs) | Moderate–High | Dabigatran: direct thrombin inhibitor (same target as hirudin — competitive). Rivaroxaban/apixaban: factor Xa inhibitors (same target as SGS antistasin). | Concurrent use is a contraindication (same class as the anticoagulants named in the books)[B1][B3]. Pausing is decided only by the prescribing physician. |
| Heparin (UFH/LMWH) | High | Antithrombin III potentiation (heparin) + direct thrombin inhibition (hirudin) = profound anticoagulation | Heparin and heparinoids are an absolute contraindication[B3]. Pausing is decided only by the prescribing physician. |
| Aspirin | Moderate | Irreversible COX-1 inhibition (aspirin) + calin/saratin-mediated platelet inhibition (SGS) = compounded antiplatelet effect | Not a contraindication by itself; fewer leeches at the first session (three to four when combined with another antiplatelet)[B3]. Do not stop it without the treating physician. |
| NSAIDs (Ibuprofen, Naproxen, etc.) | Moderate | Reversible COX inhibition + SGS antiplatelet compounds = extended bleeding | Not addressed in the hirudotherapy books; ask about bleeding tendencies and decide individually with the treating physician. |
| Thrombolytics (tPA, Streptokinase) | Very High | Systemic fibrinolysis + local anticoagulation from SGS = uncontrollable hemorrhage risk | Absolute contraindication during active thrombolytic therapy. Wait ≥24 hours after tPA completion. |
Special Populations
Pediatric Patients (<18 years)
- •Limited clinical evidence in children; most data from microsurgical case reports
- •Children require age-adjusted dosing (one leech per session under 7 years); no age cutoff is set as a contraindication (low blood volume, cooperation concerns)
- •Fluoroquinolones contraindicated under age 18 — use TMP-SMX + 3rd-generation cephalosporin for prophylaxis
- •Blood volume calculation required: term neonates ~85–90 mL/kg, children ~70–75 mL/kg — even single-leech blood loss may be hemodynamically significant
- •Enhanced parental informed consent and continuous monitoring required
Elderly Patients (>65 years)
- •Thorough polypharmacy review required (anticoagulants, antiplatelets, NSAIDs, SSRIs)
- •Reduced blood volume tolerance — lower transfusion threshold (Hgb <8 g/dL with cardiovascular disease)
- •Renal dose adjustment for fluoroquinolone prophylaxis (CrCl-based dosing)
- •Increased skin fragility — consider reduced leech application duration
- •Extended observation of bite-site bleeding: oozing usually lasts from several hours to a day, sometimes longer (Baskova & Isakhanyan; Michalsen: usually 3–12 hours)
Immunocompromised Patients
- •Marked immunosuppression (e.g., chemotherapy) and HIV infection: leech therapy is not performed (Michalsen)
- •Weakened immunity: antibiotic prophylaxis or leeches kept beforehand in an antibiotic solution (Baskova & Isakhanyan)
- •The antibiotic is chosen according to local resistance; ciprofloxacin-resistant Aeromonas has been reported
- •Infectious disease consultation recommended before initiating therapy
- •Enhanced wound surveillance with culture at the first sign of infection
Pregnancy & Lactation
- •Treatments that withdraw blood are generally contraindicated during pregnancy (Michalsen); Baskova & Isakhanyan regard the question as open
- •Level-B books (Kamenev, Savinov) treat pregnancy as a relative contraindication; this site follows the A-level books
- •A subarachnoid hemorrhage was described in a pregnant woman who applied leeches to herself (Baskova & Isakhanyan, citing Gerasimchuk 1964)
- •Lactation is not addressed in the A-level books — decide with the physician
- •Recommendation: leech therapy is not performed during pregnancy
Pre-Treatment Screening Protocol
The following standardized screening protocol should be completed before initiating any medicinal leech therapy session. This checklist is designed for integration into EMR order sets.
Laboratory Requirements
- Complete blood count (CBC) with differential
- Coagulation panel (PT/INR, aPTT)
- Type and screen, kept up to date during therapy (transfuse to keep Hgb above 8 g/dL)
- Basic metabolic panel (renal function for antibiotic dosing)
- HbA1c (diabetic patients only)
Medication Review
- Document all anticoagulants, antiplatelets, NSAIDs, SSRIs, fish oil and ginkgo
- Never stop a prescribed medicine for leech therapy without the treating physician
- Surgical patients: confirm the antibiotic plan, started at least 6 hours before, agent chosen by local resistance
- Verify no allergy to the planned antibiotic
Patient Assessment
- Assess application site for arterial sufficiency (palpable pulses, ABI if indicated)
- Screen for bleeding history (personal and family)
- Document allergy history (prior leech exposure, antibiotic allergies)
- Confirm informed consent with specific risk disclosures (bleeding, infection, scarring)
- Assess patient cooperation and psychological readiness
Institutional Readiness
- Confirm FDA-cleared leech supply available (verify species: H. verbana or H. medicinalis)
- Antibiotic prophylaxis protocol activated in EMR
- Serial hematocrit monitoring order placed (q4-8h during active treatment)
- Cross-matched blood available (for microsurgical applications)
- Biohazard waste disposal protocol in place (leeches are single-use devices)
Emergency Preparedness
All facilities performing leech therapy must have protocols for managing the following complications:
Hemorrhage
Apply direct pressure with hemostatic gauze. If bleeding persists >30 minutes: silver nitrate cautery to bite site. If hemodynamically significant: activate massive transfusion protocol. Monitor: serial Hgb/Hct q4h during active treatment.
Anaphylaxis
Standard anaphylaxis protocol: epinephrine 0.3–0.5 mg IM (1:1000), IV access, fluid resuscitation, airway management. Document SGS allergy prominently in medical record. Contraindicate future leech therapy.
Aeromonas Infection
Early signs: erythema, warmth, purulent drainage at the bite site, which can appear within 24 hours or be delayed (reported up to 26 days after the start of leech therapy). Progressive painful redness, especially with fever, calls for antibiotics at once (Michalsen). Obtain a wound culture before antibiotics if feasible and choose the agent by culture and local resistance — ciprofloxacin-resistant strains are reported. If systemic: blood cultures, IV antibiotics, surgical consultation.
Leech Migration
Prevent: apply leeches within a barrier (e.g., gauze dam). If leech migrates to body cavity: do NOT pull — apply salt or vinegar to induce detachment. ENT/surgical consultation for aerodigestive tract migration. Document and report as adverse event.
Critical Reminder
Informed Consent Requirements
References
- [B1]
Баскова И.П., Исаханян Г.С. Гирудотерапия. Наука и практика [Hirudotherapy: Science and Practice]
Monograph in Russian, 506 pp., ISBN 5-89527-058-1. Chapter 15: sensation at the bite, length of the session; secretion kininases and pain.
- [B2]
Сухов К.В. Клиническая гирудотерапия: практическое руководство. Книга 2. Приставочные и постприставочные процессы [Clinical Hirudotherapy: A Practical Guide, Book 2]
In Russian, ISBN 978-1-77192-411-5. Section 2.1 «Attachment pain».
- [B3]
Michalsen A., Roth M., Dobos G. Medicinal Leech Therapy
ISBN 978-3-13-143581-1 / 978-1-58890-563-5. Chapter 9, p. 107: perceptions of the bite — a local dragging pain lasting around one to five minutes.
The information on this page is based on the hirudotherapy books listed under References and reflects the experience their authors describe. Sensations and results differ from person to person. This information is not medical advice, a diagnosis or a prescription, and it does not replace an examination by a physician. Do not stop or change any prescribed treatment without your physician. Hirudotherapy has contraindications.